US Edition
News from european-biotechnology.com
If you want to know if European-biotechnology.com is credible or reliable, look no further. We rank European-biotechnology.com as Unknown factuality. Find out more about our methodology here.
Information about European-biotechnology.com
Where is European-biotechnology.com located?European-biotechnology.com's WebsiteMedia Bias Ratings
Do you disagree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top European-biotechnology.com News
Shanghai, China · ShanghaiSHANGHAI, Jan. 28, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), and Sinorda Biomedicine today jointly announced a strategic collaboration for the development and manufacturing of SND006, a novel bispecific antibody, for…See the Story
WuXi Biologics and Sinorda Biomedicine Enter Strategic Collaboration to Accelerate Development and Manufacturing of Innovative Bispecific Antibody
58% Center coverage: 29 sources
Eli LillyRepertoire Immune Medicines entered a strategic collaboration on Thursday with Eli Lilly and Co. (NYSE:LLY) to develop tolerizing therapies for multiple autoimmune diseases. • Eli Lilly and Co stock is showing positive momentum. Where are LLY shares going? Repertoire Immune is a biotechnology company focused on the discovery and development of programmable T cell-targeted immune medicines. Under the terms of the agreement, Repertoire will receiv…See the Story
Eli Lilly Teams Up With Two Biotechs To Target Autoimmune Disease, Hearing Loss In Deals Worth $3 Billion - Eli Lilly and Co (NYSE:LLY)
87% Center coverage: 8 sources
